ArticleJournal of clinical microbiology2014
Rapid molecular detection of inducible macrolide resistance in Mycobacterium chelonae and M. abscessus strains: a replacement for 14-day susceptibility testing?
Article in Journal of clinical microbiology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
16 citing papers in PubMed, 29 citations in OpenAlex.
- Prevalence and antimicrobial susceptibility pattern ofHeliyon · 2024Article
- Emergence of Inducible Macrolide Resistance in Mycobacterium chelonae Due to Broad-Host-Range Plasmid and Chromosomal Variants of the Novel 23S rRNA Methylase Gene,Journal of clinical microbiology · 2023Article
- A Molecular-Beacon-Based Multiplex Real-Time PCR Assay To Distinguish Mycobacterium abscessus Subspecies and Determine Macrolide Susceptibility.Journal of clinical microbiology · 2021Article
- Repurposing Avermectins and Milbemycins againstAntibiotics (Basel, Switzerland) · 2021Article
- Drug susceptibility patterns of rapidly growing mycobacteria isolated from skin and soft tissue infections in Venezuela.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2020Article
- Antimicrobial Susceptibility ofInfection and drug resistance · 2020Article
- Antimycobacterial Susceptibility Testing of Nontuberculous Mycobacteria.Journal of clinical microbiology · 2019Review
- Review
- Article
- Treating Primary Arthroprosthesis Infection Caused byCase reports in infectious diseases · 2019Article
- Whole-Genome Sequencing for Predicting Clarithromycin Resistance inAntimicrobial agents and chemotherapy · 2019Article
- Recurrence of cutaneousSAGE open medical case reports · 2019Article
- Management of a Mycobacterium immunogenum infection of a peritoneal dialysis catheter site.Infection · 2018Article
- Mycobacterium abscessus Complex Infections in Children: A Review.Current infectious disease reports · 2017Review
- Disseminated Mycobacterial Infection After International Medical Tourism.Open forum infectious diseases · 2015Article
- Absence of a functional erm gene in isolates of Mycobacterium immunogenum and the Mycobacterium mucogenicum group, based on in vitro clarithromycin susceptibility.Journal of clinical microbiology · 2015Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors at 3 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The erm(41) gene causes inducible macrolide resistance in Mycobacterium abscessus but not Mycobacterium chelonae. erm(41) sequencing of 285 M. abscessus and 45 M. chelonae isolates was compared to 14-day susceptibility; agreement percentages were 98.9% and 100%, respectively. Extended incubation may not be necessary for M. chelonae, and the erm(41) genotype is a useful adjunct for M. abscessus.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.